US2014287495A1PendingUtilityA1

Methods of Inducing Differentiation of Stem Cells

Assignee: ES CELL INT PTE LTDPriority: Jul 24, 2001Filed: Mar 25, 2014Published: Sep 25, 2014
Est. expiryJul 24, 2021(expired)· nominal 20-yr term from priority
A61P 9/04A61P 9/10A61P 3/10A61P 43/00A61P 9/00C12N 2501/10C12N 2502/28C12N 2502/02A61K 35/12C12N 5/0603C12N 5/0658C12N 5/0606C12N 2502/1329C07K 14/435C12N 2506/02C12N 2510/00C12N 2501/155C12N 5/069C12N 5/0657C12N 1/00C12R 2001/91A01K 67/00
49
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to methods of inducing differentiation of stem cells. In particular, the invention relates to methods of inducing differentiation of embryonic stem cells into muscle cells or vascular endothelial cells. The invention also includes cells, cell lines, testing models and culture systems used in the methods of the present invention and differentiated cells produced therefrom. The present invention also provides methods of using the differentiated cells of the present invention for therapeutic purposes.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 - 44 . (canceled) 
     
     
         45 . A co-culture comprising human embryonic stem cells and END2 cells. 
     
     
         46 . The co-culture of  claim 45 , further comprising cardiomyocytes. 
     
     
         47 . The co-culture of  claim 45 , further comprising cells expressing ANF, α1c, Kv4.3 and KvLQT1. 
     
     
         48 . The co-culture of  claim 46 , wherein the cardiomyocytes are beating. 
     
     
         49 . The co-culture of  claim 45  further comprising endothelial cells. 
     
     
         50 . The co-culture of  claim 45 , wherein the END2 cells have been treated with mitomycin C before being co-cultured with the human embryonic stem cells. 
     
     
         51 . The co-culture of  claim 45  further comprising FGF or BMP. 
     
     
         52 . A cell culture comprising human embryonic stem cells and media conditioned by END2 cells. 
     
     
         53 . The co-culture of  claim 52 , further comprising cardiomyocytes. 
     
     
         54 . The co-culture of  claim 52 , further comprising cells expressing ANF, α1c, Kv4.3 and KvLQT1. 
     
     
         55 . The co-culture of  claim 53 , wherein the cardiomyocytes are beating. 
     
     
         56 . The co-culture of  claim 52  further comprising endothelial cells.

Join the waitlist — get patent alerts

Track US2014287495A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.